Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genos is a world-leading biotechnology company specializing in high-throughput glycan analysis and precision medicine, based in Zagreb, Croatia. Founded in 2007 by Professor Gordan Lauc, the company has analyzed over 200,000 individual glycomes, making it one of the largest laboratories of its kind globally. Genos provides specialized glycoprofiling services to the pharmaceutical and biotech industries for biomarker discovery and therapeutic optimization, and it has commercialized the GlycanAge test to measure biological age and chronic inflammation. The company is a key partner in major international research initiatives like the Human Glycome Project and the GLUCOTYPES consortium, focusing on the role of glycans in aging, menopause, and metabolic health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genos Glyco.